COVID-19

Coronavirus: Here’s everything you need to know about the Moderna vaccine

A worker delivers protective lab coats to the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020.   REUTERS/Brian Snyder     TPX IMAGES OF THE DAY

Eight participants were reported to produce antibodies to COVID-19, in a vaccine trial by Moderna Inc. Image: REUTERS/Brian Snyder

Julie Steenhuysen
Health and science correspondent, Reuters
Share:
Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

Have you read?
Colorized scanning electron micrograph of an apoptotic cell (green) infected with SARS-COV-2 virus particles (yellow), also known as novel coronavirus, isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. National Institute of Allergy and Infectious Diseases, NIH/Handout via REUTERS. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT - RC29RF9I0B4U
If the vaccine is successful, the pharmaceutical company is hoping to supply millions of doses per month in 2020. Image: via REUTERS
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Healthcare DeliveryGlobal HealthGlobal Risks
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Here’s what to know about the new COVID-19 Pirola variant

Lora du Moulin and Charlotte Edmond

October 11, 2023

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum